Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CurePoint is an oncology healthcare company based in Dublin, Georgia, specializing in advanced radiation oncology and comprehensive cancer treatment services. Led by healthcare executive Phillip E. Miles, the company provides a multidisciplinary approach to cancer care, utilizing high-precision linear accelerators for radiation therapy alongside chemotherapy and immunotherapy. CurePoint focuses on a range of solid tumors, including prostate, bladder, and colorectal cancers, and is known for bringing international standards of care to local communities. Although the original entity underwent a Chapter 11 reorganization and was acquired in 2022, the brand continues to be associated with specialized oncology facilities in the Georgia region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CurePoint.